anthem glp-1 coverage 2026 Blue Cross Blue Shield Michigan Weight Loss Treatment New CMS Program: Certain GLP-1
Description
FY2026 coding reference.
This comprehensive review explores the mechanisms, clinical implications, and mitigation strategies, including exercise, protein intake, and adjunct therapies.
PMID: 32282828
PlexusDx explains the risks, drug interactions, and why dual-mechanism GLP-1 therapy may offer a safer personalized path forward
Most users notice better appetite regulation and digestion within 36 weeks of consistent use
